B
Biovotion
Wearable physiology monitoring company
About Biovotion
Biovotion, founded in Zurich, Switzerland, in 2011, specialized in wearable physiology monitoring, providing integrated solutions that included connected hardware and value-added services. The company was established by Dr. Andreas Caduff, an expert in non-invasive, wearable sensor technologies with a background in the pharmaceutical and medical device industries. His work focused on developing multisensor systems for wearable physiological monitoring, driven by the potential he saw in combining these devices with software ecosystems and machine learning.
Read full description
The firm developed the Everion®, a clinical-grade, multi-sensor wearable device worn on the arm. This platform was designed to non-invasively measure 22 different parameters in real-time, such as heart rate, respiratory rate, blood oxygenation, and skin temperature. It also captured insights into sleep quality, energy expenditure, and stress levels. The data collected by the Everion device was integrated into a cloud platform, providing users with health data comparable to standard hospital monitoring systems. Biovotion's business model was centered on this combination of hardware, software, and services, forming a hybrid offering for continuous health monitoring both in clinical settings and at home. The company's clients included pharmaceutical companies, contract research organizations, and healthcare providers like the Mayo Clinic and the University Hospital of Basel.
A significant milestone in the company's history occurred in November 2019, when it was acquired by Biofourmis, a Boston-based digital therapeutics company. The acquisition included Biovotion's entire portfolio, featuring the Everion biosensor and over 60 global patents for wearable sensor technology. Following the acquisition, the Biovotion team was integrated into Biofourmis, operating under the new name Biofourmis AG in Zurich. This strategic move allowed Biofourmis to incorporate Biovotion's clinical-grade wearables into its own Biovitals® ecosystem, an AI-powered analytics platform that predicts clinical exacerbations. The integration aimed to create a comprehensive digital therapeutics solution for managing complex chronic conditions like heart failure, COPD, and oncology by combining continuous physiological data with predictive analytics. Keywords: Biovotion, Biofourmis, Everion, wearable physiology monitoring, digital health, medical-grade wearable, remote patient monitoring, biosensor, vital sign monitoring, Andreas Caduff, continuous monitoring, healthcare technology, clinical-grade sensor, digital therapeutics, physiological data, health analytics, chronic disease management, non-invasive monitoring, wearable sensor technology, AI health analytics, connected health, Biovitals, remote monitoring solutions
At a glance
- Status
- Acquired
- Founded
- 2011
- Headquarters
- London, United Kingdom
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 60.6/100
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Diabetes
- Technology
- Artificial Intelligence, Hardware, Big Data, Deep Tech, Machine Learning, Computer Vision, Connected Device, IoT InternetOfThings
- Business model
- Manufacturing, Marketplace & ecommerce
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Nov 2019 | $0 | — | Biofourmis | — |
| SERIES A✓Equity / VC | Jul 2017 | $13M | $50M | Swiss RE · Harmony Medical Inc · STMicroelectronics | ↗ |
Growth signals
Latest recorded traffic for Biovotion is 220 monthly website visits, up 22.2% over the last three months. Biovotion's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
PCL HealthRemote patient monitoring and health analytics ecosystem |
London, United Kingdom | Operational | 6 | $1.4M | $6.3M |
Syrona HealthDigital therapeutics for Endometriosis and Gynaecological Health |
London, United Kingdom | Operational | |||
GiveVisionRetaining your sight for longer |
London, United Kingdom | Operational | |||
HumaProvides a digital health platform used for predictive care and research |
London, United Kingdom | Operational | |||
AparitoPlatform digitizing clinical trials with patient-generated data |
Wrexham, United Kingdom | Acquired | |||
AcurableWearable acoustic sensors for automated respiratory condition diagnosis |
London, United Kingdom | Operational | |||
Albus HealthA med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home |
Oxford, United Kingdom | Operational | |||
LifelightContactless vital signs monitoring via smartphone camera technology |
Chilworth, United Kingdom | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Swiss RE
STMicroelectronics
Harmony Medical Inc
Other known investors1 additional known investor
Biofourmis
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biovotion on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biovotion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







